10th Annual Scientific Meeting
Albuquerque, New Mexico, USA | July 17-19, 2026​​
​
The 10th Annual Scientific Meeting of the Research Society on Marijuana will be held in Albuquerque, NM, from July 17-19, 2026, at Hotel Albuquerque.
We will be celebrating our 10th anniversary where it all began. Consider submitting a symposium, panel, or individual abstract to be part of this growing community as we commemorate a decade of outstanding contributions to cannabis research.
​
​​
​
​​CALL FOR SUBMISSIONS
We are accepting proposals for Symposia and Panel Discussions, as well as Individual Abstracts for poster and paper sessions. Individual Abstracts may be considered for a poster session or, in a limited number of cases, paper sessions (oral presentations). Invitations for paper sessions will be extended to a limited number of high-quality Individual Abstracts that address one of our priority themes (see below instructions for Individual Abstracts). We also encourage symposia and panel discussion proposals that address the priority themes, but will also accept symposia and panel discussions on any topic relevant to cannabis research. We encourage individuals who are interested in presenting a talk to consider submitting as part of a symposium because we have several slots earmarked for symposia. If you would like to find other folks to collaborate with on a symposium submission, please feel free to send an email on the RSMj listserv.
To submit a symposium proposal, panel proposal, or individual abstract, please complete the form below by clicking "Submit a Proposal" at the bottom of this page. For empirical studies, please provide enough detail regarding the research question(s), method, analysis, results, and conclusion for peer-review. Priority will be given to submissions with completed data analyses. Detailed submission instructions can be found below.
​
If you have any questions, email RSMj conference submission co-chair, Jeff Wardell, directly at JWardell@yorku.ca
​
SUBMISSION DEALINES
PRIORITY DEADLINE: MARCH 16, 2026
FINAL DEADLINE: MARCH 25, 2026
​
Submissions received by the priority deadline of March 16 will be given first priority for symposium, paper session, and poster slots in the program. We will continue to accept submissions after the priority deadline until the final deadline of March 25, but we cannot guarantee that there will be space left in the program for submissions that come after the priority deadline. Acceptance notifications for submissions received by the priority deadline are expected to go out on or around April 20, 2026. Acceptance notifications for submissions received after the priority deadline may be delayed.
Travel Awards
We will once again be giving travel awards to trainees and individuals from underrepresented groups, so please be sure to check the appropriate boxes if you would like your submission to be considered for such an award. Priority for travel awards will be given to submissions that are received by the priority deadline of March 16.
​​
KEYNOTE SPEAKERS
Matthew Pearson, PhD, Founding President
Matthew R. Pearson (aka Mateo), is a Research Professor at the University of New Mexico's Center on Alcohol, Substance use, And Addictions (CASAA). Trained as an experimental psychologist, he is broadly interested in substance-related harm reduction. As the director of the Mechanisms of Addiction Treatment and Ecological Observations (MATEO) laboratory, much of his grant-funded research has used ecological momentary assessment (EMA) to test the efficacy and psychological mechanisms of various interventions ranging from mindfulness-based interventions, cognitive retraining (e.g., attentional bias modification, working memory training), and a just-in-time adaptive intervention targeting alcohol protective behavioral strategies. His lab also uses EMA to explore mechanisms naturalistically when experimental approaches are not ethical or practical like the mechanisms mobilized by mutual help group involvement (i.e., Alcoholics Anonymous). He served as the coordinating PI of several multi-site studies focused on substance use among college students including the Marijuana Outcomes Study Team (2015-2017), Protective Strategies Study Team (2017), and the Addictions Research Team (2020-present). His is the Founding President of the Research Society on Marijuana (RSMj). He is an accomplished substance use researcher and an unaccomplished comedian (and yes, he insisted on this part being included in this bio).
Adrian Bravo, PhD, Current President
Adrian J. Bravo, PhD, is an Associate Professor in the Department of Psychological Sciences at the College of William & Mary. He has a PhD in Applied Experimental Psychology from Old Dominion University. His research interests focus on identifying who is most susceptible to the development of substance use and mental health disorders, identifying under what conditions individuals engage in health risk behaviors that lead to poor mental health and problematic substance use, and identifying what factors may decouple (specifically mindfulness) the relation between health risk factors and health outcomes across distinct populations (i.e., college students, clinical populations, and military personnel). He is the Founder and Principal Investigator of the Cross-Cultural Addiction Study Team (CAST; founded in 2016), a collective of international scientists (18 investigators across 7 countries) in the behavioral sciences with a shared vision of answering meaningful research questions regarding addictive behaviors (predominately substance use) that have important global policy, prevention, and/or treatment implications. He is also the Founder and Principal Investigator of the Hispanic Addiction Research Team (HART; founded in 2023) which is a collective of scientists (12 researchers across 8 U.S. universities) in the behavioral sciences with a shared vision of answering meaningful research questions regarding addictive behaviors (predominately substance use) and mental health that have important global policy, prevention, and/or treatment implications within the U.S. Hispanic/Latino community. He has over 160 peer-reviewed publications in academic journals, serves as an Associate Editor on 3 peer-reviewed academic journals (Mindfulness, Cannabis, and Journal of Psychology and AI), and has several funded grants from the U.S. National Institute of Health, Spanish Ministry of Science, Innovation and Universities, and Argentina National Secretary of Science and Technology. Further, he is the current President of RSMj (which he co-founded in 2016).
Jane Metrik, PhD, President-Elect
Jane Metrik, Ph.D., is a Professor in the Departments of Behavioral and Social Sciences and Psychiatry and Human Behavior at Brown University, based at the Center for Alcohol and Addiction Studies (CAAS). She also holds a joint appointment at the Providence VA Medical Center as a research scientist and licensed clinical psychologist. Dr. Metrik received her training in the Joint Doctoral Program in Clinical Psychology at the University of California, San Diego/San Diego State University. She completed her clinical psychology residency at Brown University and postdoctoral fellowship at Brown’s CAAS before joining the faculty in 2007. Supported by the NIH and VA, her research focuses on cannabis behavioral pharmacology, ecological momentary assessment, and clinical trials for cannabinoid-based treatments and psychiatric comorbidities. Since establishing Brown’s first human cannabis administration laboratory 20 years ago, she has conducted the first balanced-placebo study of cannabis to disentangle pharmacologic and expectancy effects, developed paradigms for cannabis cue reactivity, and provided the first experimental evidence that cannabis acutely reduces alcohol consumption. Her recent work includes developing technology-based methods to objectively assess behavioral impairment in safety-critical activities such as driving. Collectively, her program has pioneered evidence-based approaches to cannabis science, public health, and clinical decision-making. She has contributed to 24 federally sponsored projects, serving as Principal Investigator on nine awards focused on cannabis. A dedicated mentor, Dr. Metrik is a core faculty member involved in training the next generation of clinical scientists through CAAS and Brown’s Clinical Psychology Training Consortium. She is President-Elect of the Research Society on Marijuana (RSMj).
DETAILED SUBMISSION INSTRUCTIONS
Symposium
Symposia involve a series of oral talks organized by a chair on a common theme. Symposia addressing topics similar to the paper presentation topics listed below will also be considered. Submitted talks should focus on empirical studies with completed data analysis. Overall summary abstract should be < 250 words, and each paper abstract should be < 500 words. 3-5 talks are allowed. A chair is required; a discussant is optional (but encouraged). The chair can also serve as the discussant. The overall abstract, along with the abstract for each individual talk, will be submitted together on the same form by the person submitting the symposium proposal (typically the chair).
Individual Abstracts (Poster/Paper Sessions)
Individual abstracts will be considered for poster presentations and/or paper sessions. The abstract should be < 500 words. We will consider a select number of submissions for individual paper presentations if they relate to one of the themes below. These themes have been selected to encourage submissions on topics that have had lower coverage at past conferences in order to broaden our scope. When you submit your abstract, please indicate if you'd like it to be considered only for a poster session, only for a paper session, or either a poster or paper session. Please note that while we will do our best to honor your preference, we cannot guarantee your submission will be selected for an oral paper presentation. Talks given in paper sessions will be approximately 12-14 minutes each. If you have a strong preference for an oral presentation over a poster, we encourage you to consider connecting with colleagues who conduct related research and organizing a symposium submission instead.
High-quality individual abstracts that relate to one or more of the themes below may be invited to be part of a paper session:
1) Interventions or treatment of cannabis-related disorders
2) Research examining cannabis policies, regulations, or marketing practices
3) Pre-clinical or neuroscience research
4) Community-focused research, patient oriented research, or research partnerships with individuals who have lived/living experience
Panel Discussion
Panel discussions involve the scientific discussion of an important, timely topic. All panel discussions will have a member of the Conference Program committee assigned as a moderator after panel acceptance. Overall abstract should be < 750 words and should include an explanation of the importance of the topic for discussion and a justification of the unique perspectives offered by the panel participants.
More details to follow – Check our site for any updates in the coming months, and subscribe to our listserv for the most up-to-date information!